Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2321)
All Articles published online
|
Sep 14, 2005 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Su WP, Wen CC, Hsiung CA, Su IJ, Cheng AL, Chang MC, Tsao CJ, Kao WY, Uen WC, Hsu C, Hsu CH, Lu YS, Tien HF, Chao TY, Chen LT, Whang-Peng J, Chen PJ. Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients. World J Gastroenterol 2005; 11(34): 5283-5288 [PMID: 16149133 DOI: 10.3748/wjg.v11.i34.5283] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i34/5283.htm |
| Number | Citing Articles |
| 1 |
Raymond Liang. How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation. Blood 2009; 113(14): 3147 doi: 10.1182/blood-2008-10-163493
|
| 2 |
H. E. KOHRT, D. L. OUYANG, E. B. KEEFFE. Systematic review: lamivudine prophylaxis for chemotherapy‐induced reactivation of chronic hepatitis B virus infection. Alimentary Pharmacology & Therapeutics 2006; 24(7): 1003 doi: 10.1111/j.1365-2036.2006.03081.x
|
| 3 |
Marta Davila, Harrys A. Torres. Principles and Practice of Cancer Infectious Diseases. 2011; : 189 doi: 10.1007/978-1-60761-644-3_17
|
| 4 |
Holbrook E. Kohrt, Daniel L. Ouyang, Emmet B. Keeffe. Antiviral Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus Infection. Clinics in Liver Disease 2007; 11(4): 965 doi: 10.1016/j.cld.2007.08.006
|
| 5 |
Feng Wang, Rui-hua Xu, Hui-yan Luo, Dong-shen Zhang, Wen-qi Jiang, Hui-qiang Huang, Xiao-fei Sun, Zhong-jun Xia, Zhong-zhen Guan. Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma. BMC Cancer 2008; 8(1) doi: 10.1186/1471-2407-8-115
|
| 6 |
F.J. Fernández Fernández, J. de la Fuente Aguado, R. Puerta Louro, A. Fernández Villaverde, C. Soto Ríos. Reactivación de hepatitis B tras tratamiento con CHOP y rituximab. Revista Clínica Española 2007; 207(4): 220 doi: 10.1157/13101860
|
| 7 |
Yu Xuan Koo, Daniel S. W. Tan, Iain B. Tan, Miriam Tao, Wan Cheng Chow, Soon Thye Lim. Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy. Cancer 2010; 116(1): 115 doi: 10.1002/cncr.24742
|
| 8 |
Samuel E Moses, ZiYi Lim, Mark A Zuckerman. Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients. Expert Review of Anti-infective Therapy 2011; 9(10): 891 doi: 10.1586/eri.11.105
|
| 9 |
Wenyu Li, Ling Huang, Hanguo Guo, Xiaojuan Wei, Zhanli Liang. Antiviral efficacy analysis of telbivudine concurrent with the first cycle of chemotherapy in HBsAg-positive lymphoma patients. Journal of Clinical Virology 2014; 61(2): 199 doi: 10.1016/j.jcv.2014.07.005
|
| 10 |
Hsiao-Hui Tsou, Hung-Chih Yang, Chin-Fu Hsiao, Chao A. Hsiung, Tsang-Wu Liu, Mei-Hsing Chuang, Hsiao-Yu Wu, Ya-Ting Hsu, Chiung-Wen Tsui, Pei-Jer Chen, Ann-Lii Cheng, Chiun Hsu. Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection. Journal of the Formosan Medical Association 2020; 119(1): 335 doi: 10.1016/j.jfma.2019.05.027
|
| 11 |
Xing Cao, Yafei Wang, Panyun Li, Wei Huang, Xiaojuan Lu, Hongda Lu. HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.685706
|
| 12 |
Harrys A. Torres, Marta Davila. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nature Reviews Clinical Oncology 2012; 9(3): 156 doi: 10.1038/nrclinonc.2012.1
|
| 13 |
Mubarak M. Al-Mansour, Saif A. Alghamdi, Musab A. Alsubaie, Abdullah A. Alesa, Muhammad A. Khan. Negative effect of hepatitis in overall and progression-free survival among patients with diffuse large B-cell lymphoma. Infectious Agents and Cancer 2018; 13(1) doi: 10.1186/s13027-018-0190-9
|
| 14 |
J. S. Lubel, A. G. Testro, P. W. Angus. Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management. Internal Medicine Journal 2007; 37(10): 705 doi: 10.1111/j.1445-5994.2007.01479.x
|